Suppr超能文献

评估儿科皮肤科医生、风湿病学家和神经学家在儿童皮肌炎中使用皮肤肌炎疾病面积和严重程度指数和皮肤评估工具二进制方法的可靠性。

Evaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists.

机构信息

Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, U.S.A.

Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, U.S.A.

出版信息

Br J Dermatol. 2017 Oct;177(4):1086-1092. doi: 10.1111/bjd.15596. Epub 2017 Jul 31.

Abstract

BACKGROUND

The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) and Cutaneous Assessment Tool-Binary Method (CAT-BM) have been shown to be reliable and valid outcome measures to assess cutaneous disease in adult dermatomyositis (DM) and juvenile DM (JDM), respectively.

OBJECTIVES

This study compared the CDASI and CAT-BM for use by paediatric dermatologists, paediatric rheumatologists and paediatric neurologists in patients with JDM.

METHODS

Five paediatric dermatologists, five paediatric rheumatologists and five paediatric neurologists each evaluated 14 patients with JDM using the CDASI, CAT-BM, and skin Physician Global Assessment (PGA) scales. Inter-rater reliability, intra-rater reliability, construct validity and completion time were compared.

RESULTS

Inter-rater reliability for CDASI activity and damage scores was good to moderate for paediatric dermatologists and rheumatologists, but poor for paediatric neurologists. The inter-rater reliability for CAT-BM activity scores was moderate for paediatric dermatologists and rheumatologists, but poor for paediatric neurologists and poor across all specialties for damage scores. Intra-rater reliability for the CDASI and CAT-BM activity and damage scores was moderate to excellent for paediatric dermatologists, rheumatologists and neurologists. Strong associations were found between skin PGA activity and damage scores and CDASI or CAT-BM activity and damage scores, respectively (P < 0·002). The CDASI had a mean completion time of 5·4 min compared with that for the CAT-BM of 3·1 min.

CONCLUSIONS

Our data confirm the reliability of the CDASI activity and damage scores and the CAT-BM activity scores when used by paediatric dermatologists and rheumatologists in assessing JDM. Significant variation existed in the paediatric neurologists' scores.

摘要

背景

皮肤肌炎疾病面积和严重程度指数(CDASI)和皮肤评估工具 - 二进制方法(CAT-BM)已被证明是可靠和有效的衡量指标,分别用于评估成人皮肌炎(DM)和青少年皮肌炎(JDM)的皮肤疾病。

目的

本研究比较了 CDASI 和 CAT-BM 在儿科皮肤科医生、儿科风湿病学家和儿科神经科医生评估 JDM 患者中的应用。

方法

5 名儿科皮肤科医生、5 名儿科风湿病学家和 5 名儿科神经科医生分别使用 CDASI、CAT-BM 和皮肤医师整体评估(PGA)量表评估 14 名 JDM 患者。比较了组内可靠性、组内可靠性、结构有效性和完成时间。

结果

对于儿科皮肤科医生和风湿病学家,CDASI 活动和损伤评分的组内可靠性为良好至中度,但对于儿科神经科医生则较差。儿科皮肤科医生和风湿病学家的 CAT-BM 活动评分的组内可靠性为中度,但对于儿科神经科医生则较差,并且对于所有专业来说,损伤评分都较差。儿科皮肤科医生、风湿病学家和神经科医生的 CDASI 和 CAT-BM 活动和损伤评分的组内可靠性为中度至极好。皮肤 PGA 活动和损伤评分与 CDASI 或 CAT-BM 活动和损伤评分之间存在很强的相关性(P<0.002)。CDASI 的平均完成时间为 5.4 分钟,而 CAT-BM 的平均完成时间为 3.1 分钟。

结论

我们的数据证实了 CDASI 活动和损伤评分以及 CAT-BM 活动评分在儿科皮肤科医生和风湿病学家评估 JDM 时的可靠性。儿科神经科医生的评分存在显著差异。

相似文献

3
Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.
J Invest Dermatol. 2012 Apr;132(4):1117-24. doi: 10.1038/jid.2011.440. Epub 2012 Jan 5.
4
Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.
Br J Dermatol. 2008 Sep;159(4):887-94. doi: 10.1111/j.1365-2133.2008.08711.x. Epub 2008 Jul 4.
8
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.
Rheumatology (Oxford). 2007 Oct;46(10):1606-11. doi: 10.1093/rheumatology/kem179.
9
Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM).
Pediatr Rheumatol Online J. 2023 Jun 28;21(1):63. doi: 10.1186/s12969-023-00844-5.
10
Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument.
Br J Dermatol. 2010 Mar;162(3):669-73. doi: 10.1111/j.1365-2133.2009.09521.x. Epub 2009 Oct 26.

引用本文的文献

1
Tape strip expression profiling of juvenile dermatomyositis skin reveals mitochondrial dysfunction contributing to disease endotype.
JCI Insight. 2025 Mar 13;10(8). doi: 10.1172/jci.insight.179875. eCollection 2025 Apr 22.
3
Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM).
Pediatr Rheumatol Online J. 2023 Jun 28;21(1):63. doi: 10.1186/s12969-023-00844-5.
6
Importance of collaboration of dermatology and rheumatology to advance the field for lupus and dermatomyositis.
Int J Womens Dermatol. 2021 Sep 24;7(5Part A):583-587. doi: 10.1016/j.ijwd.2021.09.002. eCollection 2021 Dec.
7
Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes.
Rheum Dis Clin North Am. 2021 Nov;47(4):669-690. doi: 10.1016/j.rdc.2021.07.003. Epub 2021 Sep 2.
8
Outcome Scores in Pediatric Rheumatology.
Curr Rheumatol Rep. 2021 Mar 8;23(4):23. doi: 10.1007/s11926-021-00988-x.
10
Advances Toward Precision Medicine in Juvenile Dermatomyositis.
Curr Rheumatol Rep. 2019 Dec 7;21(12):73. doi: 10.1007/s11926-019-0873-2.

本文引用的文献

1
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.
Arthritis Care Res (Hoboken). 2016 Oct;68(10):1514-21. doi: 10.1002/acr.22867. Epub 2016 Sep 16.
5
Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.
J Invest Dermatol. 2012 Apr;132(4):1117-24. doi: 10.1038/jid.2011.440. Epub 2012 Jan 5.
6
Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument.
Br J Dermatol. 2010 Mar;162(3):669-73. doi: 10.1111/j.1365-2133.2009.09521.x. Epub 2009 Oct 26.
7
Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.
Br J Dermatol. 2008 Sep;159(4):887-94. doi: 10.1111/j.1365-2133.2008.08711.x. Epub 2008 Jul 4.
8
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
Lancet. 2008 Jun 28;371(9631):2201-12. doi: 10.1016/S0140-6736(08)60955-1.
9
The treatment and prognosis of dermatomyositis: an updated review.
J Am Acad Dermatol. 2008 Jul;59(1):99-112. doi: 10.1016/j.jaad.2008.02.043. Epub 2008 Apr 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验